Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
Neurology Minute · American Academy of Neurology
May 14, 20192m 24s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Ivan Sanchez Fernandez discusses the main points from his paper on meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus.